• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测帕金森病的运动功能衰退和残疾:一项系统评价

Predicting motor decline and disability in Parkinson disease: a systematic review.

作者信息

Marras Connie, Rochon Paula, Lang Anthony E

机构信息

Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada.

出版信息

Arch Neurol. 2002 Nov;59(11):1724-8. doi: 10.1001/archneur.59.11.1724.

DOI:10.1001/archneur.59.11.1724
PMID:12433259
Abstract

CONTEXT

The clinical course of Parkinson disease (PD) varies from patient to patient. A number of studies investigating predictors of prognosis in patients with PD have been performed.

OBJECTIVE

To summarize evidence on predicting the rate of motor decline and increasing disability in early PD.

DATA SOURCES

English-language and French-language literature cited in the MEDLINE database (1966-2002).

STUDY SELECTION

Cohort and case-control studies investigating associations between clinical features and subsequent motor impairment or disability were selected.

DATA EXTRACTION

Study methods and results were abstracted by a single reviewer.

DATA SYNTHESIS

The results of 13 studies were summarized qualitatively. Study methods were highly variable, particularly regarding the choice of outcome measure. Baseline motor impairment and cognitive impairment are probable predictors of more rapid motor decline and disability. A lack of tremor at onset and older age both appear to be predictive of increasing disability, but conflicting results exist for their association with the rate of change of motor impairment. Family history of PD does not appear to be prognostically important. The prognostic value of many other factors studied is uncertain owing to conflicting or unconfirmed results.

CONCLUSIONS

Uncertainty remains about the prognostic importance of many baseline clinical features in PD. Greater baseline impairment, early cognitive disturbance, older age, and lack of tremor at onset appear to be adverse prognostic factors.

摘要

背景

帕金森病(PD)的临床病程因患者而异。已经开展了多项研究来调查PD患者预后的预测因素。

目的

总结关于预测早期PD运动功能衰退率和残疾程度增加的证据。

数据来源

MEDLINE数据库(1966 - 2002年)中引用的英文和法语文献。

研究选择

选择了调查临床特征与随后的运动障碍或残疾之间关联的队列研究和病例对照研究。

数据提取

由一名审阅者提取研究方法和结果。

数据综合

对13项研究的结果进行了定性总结。研究方法差异很大,尤其是在结局测量的选择方面。基线运动障碍和认知障碍可能是运动功能衰退加快和残疾的预测因素。发病时无震颤和年龄较大似乎都预示着残疾程度增加,但它们与运动障碍变化率的关联存在相互矛盾的结果。PD家族史似乎在预后方面并不重要。由于结果相互矛盾或未经证实,许多其他研究因素的预后价值尚不确定。

结论

关于PD许多基线临床特征的预后重要性仍存在不确定性。基线损害较重、早期认知障碍、年龄较大和发病时无震颤似乎是不良预后因素。

相似文献

1
Predicting motor decline and disability in Parkinson disease: a systematic review.预测帕金森病的运动功能衰退和残疾:一项系统评价
Arch Neurol. 2002 Nov;59(11):1724-8. doi: 10.1001/archneur.59.11.1724.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Anticholinergics for symptomatic management of Parkinson's disease.用于帕金森病症状管理的抗胆碱能药物。
Cochrane Database Syst Rev. 2003;2002(2):CD003735. doi: 10.1002/14651858.CD003735.
4
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
5
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
6
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).静脉注射脂质体GM1治疗帕金森病患者的安全性和耐受性:一项单中心开放标签的I期临床试验(NEON试验)。
PLoS Med. 2025 May 13;22(5):e1004472. doi: 10.1371/journal.pmed.1004472. eCollection 2025 May.
10
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease.一年的练习效果可预测帕金森病的长期认知结果。
J Parkinsons Dis. 2025 Apr 29:1877718X251339585. doi: 10.1177/1877718X251339585.

引用本文的文献

1
Parkinson's disease with possible REM sleep behavior disorder correlated with more severe glymphatic system dysfunction.伴有可能的快速眼动睡眠行为障碍的帕金森病与更严重的类淋巴系统功能障碍相关。
NPJ Parkinsons Dis. 2025 Apr 21;11(1):82. doi: 10.1038/s41531-025-00962-9.
2
The natural history of body-first versus brain-first Parkinson's disease subtypes.身体优先与大脑优先帕金森病亚型的自然病史。
J Neurol. 2025 Apr 9;272(5):325. doi: 10.1007/s00415-025-13050-y.
3
How Information Affects Patients with Parkinson's Disease: A Scoping Review of the Literature.
信息如何影响帕金森病患者:文献综述
J Parkinsons Dis. 2024;14(6):1115-1127. doi: 10.3233/JPD-240073.
4
Psychometrics and diagnostics of the Italian version of the Alternate Verbal Fluency Battery (AVFB) in non-demented Parkinson's disease patients.非痴呆帕金森病患者意大利版替代言语流畅性测验(AVFB)的心理测量学与诊断研究
Neurol Sci. 2024 Aug;45(8):3767-3774. doi: 10.1007/s10072-024-07436-5. Epub 2024 Mar 11.
5
Distinct changes in global brain synchronization in different motor subtypes of Parkinson's disease.帕金森病不同运动亚型中全脑同步性的明显变化。
Front Neurosci. 2023 Oct 18;17:1170225. doi: 10.3389/fnins.2023.1170225. eCollection 2023.
6
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.帕金森病的心脏123I-间碘苄胍(MIBG)闪烁扫描术:一项综述
Brain Sci. 2023 Oct 18;13(10):1471. doi: 10.3390/brainsci13101471.
7
The effects of medical comorbidity, cognition, and age on patient-reported outcomes in Parkinson's disease.医学合并症、认知功能和年龄对帕金森病患者报告结局的影响。
Parkinsonism Relat Disord. 2023 Nov;116:105892. doi: 10.1016/j.parkreldis.2023.105892. Epub 2023 Oct 10.
8
Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.意大利版蒙特利尔认知评估量表(MoCA)在非痴呆帕金森病患者中的有效性和诊断学研究。
Aging Clin Exp Res. 2023 Oct;35(10):2157-2163. doi: 10.1007/s40520-023-02493-w. Epub 2023 Jul 22.
9
Two-year clinical progression in focal and diffuse subtypes of Parkinson's disease.帕金森病局灶性和弥漫性亚型的两年临床进展
NPJ Parkinsons Dis. 2023 Feb 17;9(1):29. doi: 10.1038/s41531-023-00466-4.
10
Intra-individual variability in cognitive performance predicts functional decline in Parkinson's disease.帕金森病认知功能的个体内变异性可预测功能衰退。
Appl Neuropsychol Adult. 2025 Jan-Feb;32(1):125-132. doi: 10.1080/23279095.2022.2157276. Epub 2023 Jan 10.